Your Article Summary
See Latest ArticlesEvidence-based management of ANCA vasculitis
Best Practice & Research: Clinical Rheumatology, 06/29/09
Carruthers D et al. - Treatment strategies for these primary inflammatory vascular diseases have varied based on the outcomes of different clinical trials and practice reviews. The individual drugs used and their route of administration, dose, and duration of therapy have varied and have been the source of much debate. Advances in the understanding of disease immunopathogenesis, clinical assessment and outcome have formed the basis for several recent good-quality clinical trials.
Related Articles
Rituximab may form a complex with iGm[kappa] mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
Arthritis & Rheumatism, 12/03/09
Relevance Score: 90%%
Systemic vasculitis in childhood
Current Rheumatology Reports, 12/03/09
Relevance Score: 88%%
Small vessel vasculitis
Pediatric Nephrology, 11/11/09
Relevance Score: 88%%
Serum concentrations of interleukin 1î², cxcl10, and interferon-î³ in mixed cryoglobulinemia associated with hepatitis c infection
Journal of Rheumatology, 11/20/09
Relevance Score: 85%%
Ciprofloxacin-Induced Hemorrhagic Vasculitis
Annals of Vascular Surgery, 11/09/09
Relevance Score: 85%%
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Journal of the European Academy of Dermatology and Venereology, 12/04/09
Study on association between polymorphism of HLA-DRB1 alleles and Behcet's disease
Journal of the European Academy of Dermatology and Venereology, 12/04/09
Rituximab may form a complex with iGm[kappa] mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
Arthritis & Rheumatism, 12/03/09